DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
McGregor BA, Lalani A-K, Xie W. et al.
Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC.
Ann Oncol 2018;
29 (Suppl. 08) VIII311
Access:
We do not assume any responsibility for the contents of the web pages of other providers.